BIOTRONIK’s MultiPole Pacing for CRT Defibrillators Now Approved in U.S.

BIOTRONIK won FDA approval for its MultiPole Pacing (MPP) technology to be introduced in the U.S. on its CRT defibrillators (CRT-Ds). It’s designed to address the fact that the hearts of many patients on cardiac resynchronization therapy (CRT) fail to respond properly, and allowing cardiologists more pacing options can help overcome that in (Read more...)

Full Story →